{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:15:59Z","timestamp":1782969359535,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jep.2023.116646","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:25:13Z","timestamp":1685647513000},"page":"116646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["FZKA reverses gefitinib resistance by regulating EZH2\/Snail\/EGFR signaling pathway in lung adenocarcinoma"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-4810","authenticated-orcid":false,"given":"Qing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changju","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-4019","authenticated-orcid":false,"given":"Sumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jep.2023.116646_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jtho.2016.12.014","article-title":"Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer","volume":"12","author":"Castellanos","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13046-019-1234-8","article-title":"Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41419-020-03047-y","article-title":"Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.jep.2023.116646_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jtho.2021.11.025","article-title":"A phase 1\/2 study of lazertinib 240 mg in patients with advanced EGFR t790m-positive NSCLC after previous EGFR tyrosine kinase inhibitors","volume":"17","author":"Cho","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.jep.2023.116646_bib5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-19-3326","article-title":"The EZH2-PHACTR2-AS1-ribosome Axis induces genomic instability and promotes growth and metastasis in breast cancer","volume":"80","author":"Chu","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jep.2023.116646_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2020.10.012","article-title":"SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth","volume":"180","author":"Edwards","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.jep.2023.116646_bib8","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.jep.2023.116646_bib9","first-page":"255","article-title":"[Role of EZH2 inhibitor combined with gefitinib in EGFR-TKIs resistant lung cancer cells]","volume":"22","author":"Gong","year":"2019","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3","key":"10.1016\/j.jep.2023.116646_bib10","first-page":"1168","article-title":"LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer","volume":"24","author":"Gong","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jep.2023.116646_bib11","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.2147\/OTT.S235643","article-title":"The pseudogene DUXAP8 promotes colorectal cancer cell proliferation, invasion, and migration by inducing epithelial-mesenchymal transition through interacting with EZH2 and H3K27me3","volume":"13","author":"He","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.jep.2023.116646_bib12","doi-asserted-by":"crossref","first-page":"152805","DOI":"10.1016\/j.phymed.2018.12.028","article-title":"Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1\/2 and p38 MAPK signaling pathway","volume":"58","author":"Hsieh","year":"2019","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.jep.2023.116646_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13258-020-00963-3","article-title":"MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL\/PI3K\/AKT\/Snail signaling in nasopharyngeal carcinoma","volume":"42","author":"Jiang","year":"2020","journal-title":"Genes Genomics"},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/thno.27246","article-title":"Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin \u03b23\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery","volume":"9","author":"Jin","year":"2019","journal-title":"Theranostics"},{"issue":"43","key":"10.1016\/j.jep.2023.116646_bib15","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1038\/onc.2013.452","article-title":"A comparative survey of functional footprints of EGFR pathway mutations in human cancers","volume":"33","author":"Lane","year":"2014","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.jep.2023.116646_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031102","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/s41388-019-1132-8","article-title":"A TGF-\u03b2-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jep.2023.116646_bib18","doi-asserted-by":"crossref","first-page":"109090","DOI":"10.1016\/j.biopha.2019.109090","article-title":"In vitro effect of Pannexin 1 channel on the invasion and migration of I-10 testicular cancer cells via ERK1\/2 signaling pathway","volume":"117","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAI.0000000000000965","article-title":"Cytoplasmic P120ctn promotes gefitinib resistance in lung cancer cells by activating PAK1 and ERK pathway","volume":"29","author":"Liu","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"30","key":"10.1016\/j.jep.2023.116646_bib21","doi-asserted-by":"crossref","first-page":"50209","DOI":"10.18632\/oncotarget.16854","article-title":"Epidermal growth factor receptor (EGFR): a rising star in the era of precision medicine of lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.jep.2023.116646_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23148025","article-title":"Targeted Co-delivery of gefitinib and rapamycin by aptamer-modified nanoparticles overcomes EGFR-TKI resistance in NSCLC via promoting autophagy","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41419-020-03041-4","article-title":"B7-H3 regulates KIF15-activated ERK1\/2 pathway and contributes to radioresistance in colorectal cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib24","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1038\/s41467-021-26222-x","article-title":"FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth","volume":"12","author":"Niu","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jep.2023.116646_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"19","key":"10.1016\/j.jep.2023.116646_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194926","article-title":"Molecular mechanism of EGFR-TKI resistance in EGFR-mutated non-small cell lung cancer: application to biological diagnostic and monitoring","volume":"13","author":"Reita","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.jep.2023.116646_bib28","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1002\/jcp.29269","article-title":"Chlorogenic acid activates ERK1\/2 and inhibits proliferation of osteosarcoma cells","volume":"235","author":"Sapio","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.jep.2023.116646_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","article-title":"Tazemetostat: EZH2 inhibitor","volume":"13","author":"Straining","year":"2022","journal-title":"J Adv Pract Oncol"},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12931-020-01477-y","article-title":"FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer","volume":"21","author":"Sun","year":"2020","journal-title":"Respir. Res."},{"issue":"11","key":"10.1016\/j.jep.2023.116646_bib31","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1111\/jcmm.14649","article-title":"Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer","volume":"23","author":"Tang","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.jep.2023.116646_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2020.09.003","article-title":"POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1\/2 signaling pathway","volume":"533","author":"Wu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2023.116646_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.omtn.2020.02.006","article-title":"Long noncoding RNA RC3H2 facilitates cell proliferation and invasion by targeting MicroRNA-101-3p\/EZH2 Axis in OSCC","volume":"20","author":"Wu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41420-021-00744-1","article-title":"Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.jep.2023.116646_bib35","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ctim.2014.10.001","article-title":"Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study","volume":"22","author":"Yang","year":"2014","journal-title":"Compl. Ther. Med."},{"key":"10.1016\/j.jep.2023.116646_bib36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13063-015-0685-2","article-title":"Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial","volume":"16","author":"Yang","year":"2015","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.jep.2023.116646_bib37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11655-017-2819-8","article-title":"Gefitinib plus Fuzheng kang'ai formula ( ) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized controlled trial","volume":"24","author":"Yang","year":"2018","journal-title":"Chin. J. Integr. Med."},{"issue":"3","key":"10.1016\/j.jep.2023.116646_bib38","first-page":"2783","article-title":"Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT\/GSK-3\u03b2\/Snail signaling pathway","volume":"20","author":"Yuan","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.jep.2023.116646_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122639","article-title":"Cooperation and interplay between EGFR signalling and extracellular vesicle biogenesis in cancer","volume":"9","author":"Zanetti-Domingues","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jep.2023.116646_bib40","first-page":"160","article-title":"Knockdown of TRIM66 in MDA-MB-468 triple negative breast cancer cell line suppresses proliferation and promotes apoptosis through EGFR signaling","volume":"72","author":"Zhang","year":"2021","journal-title":"Pol. J. Pathol."},{"issue":"5","key":"10.1016\/j.jep.2023.116646_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jep.2023.116646_bib42","doi-asserted-by":"crossref","first-page":"851680","DOI":"10.3389\/fphar.2022.851680","article-title":"GPX4 plays a crucial role in Fuzheng kang'ai decoction-induced non-small cell lung cancer cell ferroptosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2023.116646_bib43","doi-asserted-by":"crossref","first-page":"5060757","DOI":"10.1155\/2016\/5060757","article-title":"Chinese herbal medicine Fuzheng kang-ai decoction inhibited lung cancer cell growth through AMPK\u03b1-mediated induction and interplay of IGFBP1 and FOXO3a","volume":"2016","author":"Zheng","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jep.2023.116646_bib44","doi-asserted-by":"crossref","first-page":"111928","DOI":"10.1016\/j.jep.2019.111928","article-title":"The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib","volume":"239","author":"Zheng","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2023.116646_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123005147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123005147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:01:53Z","timestamp":1736402513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874123005147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S0378874123005147"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.116646","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FZKA reverses gefitinib resistance by regulating EZH2\/Snail\/EGFR signaling pathway in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.116646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116646"}}